Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

June 15, 2023 00:30:21
Episode Cover

Do Etomidate and Propofol Increase Mortality in the Critically Ill?

Both etomidate and propofol are commonly used sedative agents in critically ill patients.  Recent literature has suggested that these agents may result in increased...

Listen

Episode 0

March 18, 2022 00:30:35
Episode Cover

The Critically Ill Patient with HHS

Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients...

Listen

Episode 0

February 28, 2023 00:27:55
Episode Cover

ECPR for OHCA? - The INCEPTION Trial

In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received...

Listen